AFAR Honorary Leadership Awarded to Nathaniel David

In July, AFAR presented its 2017 Honorary Leadership Award to Nathaniel “Ned” David, Ph.D. for his dedication to healthy aging and his role in helping advance some of the most significant research discoveries and potential interventions. A biochemist and biotech entrepreneur who has founded four visionary biotech companies, Dr. David co-founded UNITY in 2011 along with three of the leading researchers in the field of cellular senescence, including AFAR grantee Judith Campisi, Ph.D. In his acceptance speech, David spoke passionately about how AFAR’s early support of Campisi’s research has made a major impact on…

The Architects of Aging: Biotechnology and Longevity Panel

On July 25, 2017 at the Westin St. Francis in San Franciso, AFAR hosted a panel of innovators in longevity and biotechnology. Moderated by Jamie Metzl (Atlantic Council Senior Fellow for Biotechnology and National Security), the panel featured: AFAR Deputy Scientific Nir Barzilai, MD; Judith Campisi, PhD of the Buck Institute for Research on Aging; Nathaniel "Ned" David, PhD of Unity Biotechnology; Jan van Deursen, PhD of the Mayo Clinic; and Eric Verdin, M.D. of the Buck Institute for Research on Aging. Special thanks to Unity Biotechnology for capturing the discussion here.